Abstract
Although it is considered rare, stimulant-induced psychosis is one of the most serious and unpleasant adverse events during attention deficit/hyperactivity disorder (ADHD) treatment. There is a need to update regularly the current state of knowledge on this topic to improve quality of care. For this reason, we reviewed relevant publications using Pubmed database, for the period 2003-2012. It came out that the amount of publications, which are predominantly case reports, on this topic are limited for this period. Previous trend of publication and state of knowledge continues. Newer atypical antipsychotics, which complicate stimulant treatment in ADHD, is an emerging dimension. We suggest more research and ongoing clinical vigilance to reach an advanced understanding of the topic.
Keywords: Adverse effect, ADHD, CNS stimulant drugs, drug-induced psychosis, mania, methylphenidate, psychoactive drugs.
Current Psychopharmacology
Title:Stimulant-Related Psychosis in ADHD Treatment: An Update for Past 10 Years
Volume: 2
Author(s): Gresa C. Bulut, Seheryeli Y. Kaynar and Osman Sabuncuoglu
Affiliation:
Keywords: Adverse effect, ADHD, CNS stimulant drugs, drug-induced psychosis, mania, methylphenidate, psychoactive drugs.
Abstract: Although it is considered rare, stimulant-induced psychosis is one of the most serious and unpleasant adverse events during attention deficit/hyperactivity disorder (ADHD) treatment. There is a need to update regularly the current state of knowledge on this topic to improve quality of care. For this reason, we reviewed relevant publications using Pubmed database, for the period 2003-2012. It came out that the amount of publications, which are predominantly case reports, on this topic are limited for this period. Previous trend of publication and state of knowledge continues. Newer atypical antipsychotics, which complicate stimulant treatment in ADHD, is an emerging dimension. We suggest more research and ongoing clinical vigilance to reach an advanced understanding of the topic.
Export Options
About this article
Cite this article as:
Bulut C. Gresa, Kaynar Y. Seheryeli and Sabuncuoglu Osman, Stimulant-Related Psychosis in ADHD Treatment: An Update for Past 10 Years, Current Psychopharmacology 2013; 2 (3) . https://dx.doi.org/10.2174/22115560113029990005
DOI https://dx.doi.org/10.2174/22115560113029990005 |
Print ISSN 2211-5560 |
Publisher Name Bentham Science Publisher |
Online ISSN 2211-5579 |
Call for Papers in Thematic Issues
Breakthroughs in drug design, development and delivery system for the management of neuro-psychiatric disorders
Neuropsychiatric diseases are one of the main causes of disability, affecting millions of people. Various drugs are used for its treatment, although no effective therapy has been found yet. The blood brain barrier (BBB) significantly complicates drugs delivery to the target cells in the brain tissues. This proposal describes the ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Achievements and Limitations of Complement Inhibition by Eculizumab in Paroxysmal Nocturnal Hemoglobinuria: The Role of Complement Component 3
Mini-Reviews in Medicinal Chemistry Antitumor Effect of Butanoylated Heparin with Low Anticoagulant Activity on Lung Cancer Growth in Mice and Rats
Current Cancer Drug Targets Treatment of the Motor and Non-Motor Symptoms in Parkinson's Disease According to Cluster Symptoms Presentation
Current Drug Targets Editorial [Hot topic: Controversies in Hypertension Treatment (Guest Editors: Maciej Banach, Sverre E. Kjeldsen and Krzysztof Narkiewicz)]
Current Vascular Pharmacology HCN Channels Modulators: The Need for Selectivity
Current Topics in Medicinal Chemistry Epigenetic Alterations in DNA and Histone Modifications Caused by Depression and Antidepressant Drugs: Lessons from the Rodent Models
Current Pharmaceutical Design Hydroxyimine NO-Donors; FK409 and Derivatives
Current Topics in Medicinal Chemistry Quantitative Analysis in Cardiovascular Imaging: Current Status
Current Medical Imaging Proteomics Approaches to Understand Linkage Between Alzheimer’s Disease and Type 2 Diabetes Mellitus
CNS & Neurological Disorders - Drug Targets Prevention of Ischemic Stroke: Overview of Traditional Risk Factors
Current Drug Targets Basal Ganglia Enlarged Perivascular Spaces are Linked to Cognitive Function in Patients with Cerebral Small Vessel Disease
Current Neurovascular Research Body Mass Index (BMI) and Cognitive Functions in Later Life
Current Alzheimer Research Clinical Features and Disease Damage Risk Factors in an Egyptian SLE Cohort: A Multicenter Study
Current Rheumatology Reviews Lifestyle Interventions for Cardiovascular Risk Reduction in Women with Breast Cancer
Current Cardiology Reviews Cellular Balance, Genes,and the Huang Ti Nei Ching Su Wen
Current Neurovascular Research Role of Asymmetric Dimethylarginine (ADMA) in Diabetic Vascular Complications
Current Pharmaceutical Design The Endocrine Function of Adipose Tissue
Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents Risk-Benefit Perspectives in COX-2 Blockade
Current Drug Safety Microparticles: From Biogenesis to Biomarkers and Diagnostic Tools in Cardiovascular Disease
Current Stem Cell Research & Therapy Preparation and Evaluation of Chitosan Submicroparticles Containing Pilocarpine for Glaucoma Therapy
Current Drug Delivery